|
|
| American Medical Systems Receives the First FDA Marketing Approval of An Antibiotic-Treated Permanent Implant |
| AMERICAN MEDICAL SYSTEMS LOGO
American Medical Systems, Inc. logo. (PRNewsFoto)[AG] MINNEAPOLIS, MN USA | |||
MINNEAPOLIS, May 1 /PRNewswire/ -- American Medical Systems (Nasdaq: AMMD) today reported receipt of marketing approval by the U.S. Food and Drug Administration of the company's unique antibiotic surface treatment on the AMS 700 series penile prostheses. The FDA's action is its first approval of an antibiotic surface treatment for a permanent implantable device. (Photo: http://www.newscom.com/cgi-bin/prnh/20000710/AMSLOGO ) The surface treatment, known as InhibiZone(TM), is impregnated through a patented process into the tissue-contacting surfaces of the prostheses. In laboratory testing, the device elutes the drugs from the surface when exposed to a warm, moist environment, providing antibiotic action both on the surface and in a zone surrounding the treated device. Zones of inhibition have been demonstrated in laboratory testing and have not been verified in clinical studies. "We are pleased by the thorough FDA review and approval of InhibiZone," said Doug Kohrs, AMS president and CEO. "Improvement of all AMS products is a continuing focus of the company's development efforts because we realize that the patient's peace of mind is an important component of any medical therapy. Physicians and patients will welcome this medical advancement in device therapy, which comes at a time when many men who fail pharmaceutical treatments for erectile dysfunction are exploring other treatments." About 30 million American men between the ages of 40 and 70 are afflicted with erectile dysfunction (ED), which makes it difficult or impossible for them to achieve erections sufficient for sexual intercourse. Almost 3 million are serious, chronic cases and more than 1.1 million of these men annually are inadequately served by pharmaceutical therapies for ED and may be candidates to receive a penile prosthesis. American Medical Systems developed the first inflatable penile prosthesis in 1973 and now offers a family of devices addressing various patient needs. More than 200,000 of the company's prostheses have been successfully implanted and their use is widely accepted as one of the most effective long-term treatments for ED. American Medical Systems (AMS), headquartered in Minneapolis, is a medical technology company dedicated to surgeon-choice urological solutions for both male and female incontinence, devices for the diagnosis and treatment of erectile dysfunction; and obstructions related to prostate disease. The company markets its products in more than 60 countries worldwide. For more information about AMS and its products, call 800-328-3881 or visit http://www.visitAMS.comSOURCE American Medical Systems
back to topRelated links:
Photo Notes:
NewsCom:
http://www.newscom.com/cgi-bin/prnh/20000710/AMSLOGO
AP Archive: http://photoarchive.ap.org
PRN Photo Desk, 888-776-6555 or 201-369-3467
CONTACT:
Greg Melsen, Chief Financial Officer,
952-930-4666, greg.melsen@visitAMS.com , or Kimberly Eggen,
Public Relations, 952-930-6326, 800-328-3881, ext. 6326,
kim.eggen@visitams.com , both of American Medical Systems
